daclatasvir

Explore academic connections and research related to this keyword

110
Views
22
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Inhibitory Effects of Amentoflavone and Orobol on Daclatasvir-Induced Resistance-Associated Variants of Hepatitis C Virus.
Lee, Wei-Ping;Lan, Keng-Li;Liao, Shi-Xian;Huang, Yi-Hsiang;Hou, Ming-Chih;Lan, Keng-Hsin;
2018 The American journal of Chinese medicine DOI: 10.1142/S0192415X185... 283 views
2
hemodialysis patients treated for hepatitis c using a sofosbuvir-based regimen
;Sanjay Kumar Agarwal;Soumita Bagchi;Raj Kumar Yadav
2017 Soft matter DOI: 10.1016/j.ekir.2017.... 173 views
3
Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]
Amro M Hassan;Heba A Osman;Hasan S Mahmoud;Mohammed H Hassan;Abdel-Kader A Hashim;Hesham H Ameen and
2019 Infection and drug resistance DOI: 10.2147/IDR.S216102 276 views
4
Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study
Mohamed A Mekky;Hani I Sayed;Mohamed O Abdelmalek;Medhat A Saleh;Osman A Osman;Heba A Osman;Khairy H...
2019 Infection and drug resistance DOI: 10.2147/IDR.S181638 301 views
5
Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience
Amro M Hassan;Heba A Osman;Hasan S Mahmoud;Mohammed H Hassan;Abdel-Kader A Hashim;Hesham H Ameen and
2018 Infection and drug resistance DOI: 10.2147/IDR.S167093 298 views
6
Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection
Ossama A Ahmed;Mohamed A Elsebaey;Mohamed Hassan A Fouad;Heba Elashry;Ahmed I Elshafie;Ahmed A Elhad...
2018 Infection and drug resistance DOI: 10.2147/IDR.S160593 282 views
7
Approaches to hepatitis C treatment and cure using NS5A inhibitors
James J Kohler;James H Nettles;Franck Amblard;Selwyn J Hurwitz;Leda Bassit;Richard A Stanton;Maryam...
2014 Infection and drug resistance DOI: 10.2147/IDR.S36247 196 views
8
Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]
2019 Infection and drug resistance DOI: 10.2147/IDR.S216102 277 views
9
Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]
Amro M Hassan;Heba A Osman;Hasan S Mahmoud;Mohammed H Hassan;Abdel-Kader A Hashim;Hesham H Ameen;
2019 Infection and drug resistance DOI: 10.2147/IDR.S216102 268 views
10
Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study
Mohamed A Mekky;Hani I Sayed;Mohamed O Abdelmalek;Medhat A Saleh;Osman A Osman;Heba A Osman;Khairy H...
2019 Infection and drug resistance DOI: 10.2147/IDR.S181638 294 views
11
Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience
Amro M Hassan;Heba A Osman;Hasan S Mahmoud;Mohammed H Hassan;Abdel-Kader A Hashim;Hesham H Ameen;
2018 Infection and drug resistance DOI: 10.2147/IDR.S167093 323 views
12
Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection
Ossama A Ahmed;Mohamed A Elsebaey;Mohamed Hassan A Fouad;Heba Elashry;Ahmed I Elshafie;Ahmed A Elhad...
2018 Infection and drug resistance DOI: 10.2147/IDR.S160593 307 views
13
Approaches to hepatitis C treatment and cure using NS5A inhibitors
James J Kohler;James H Nettles;Franck Amblard;Selwyn J Hurwitz;Leda Bassit;Richard A Stanton;Maryam...
2014 Infection and drug resistance DOI: 10.2147/IDR.S36247 188 views
14
The Evolution of Hepatitis C Treatment
Sofian, Masoomeh;
2018 majallah-i dānishgāh-i ̒ulūm-i pizishkī-i arāk 178 views
15
Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies
Baker, M.
2019 drug development and industrial pharmacy DOI: 10.1080/03639045.201... 278 views
16
Discovery of a novel unsymmetrical structural class of HCV NS5A inhibitors with low picomolar antiviral activity.
Nakamura, Hiroshi;Akagi, Yusuke;Terui, Takashi;Fujioka, Shingo;Komoda, Yasumasa;Kinoshita, Wataru;Ma...
2019 Bioorganic & medicinal chemistry letters DOI: S0960-894X(19)30915-... 208 views
18
Minimum costs to manufacture new treatments for COVID-19.
Hill, Andrew;Wang, Junzheng;Levi, Jacob;Heath, Katie;Fortunak, Joseph;
2020 journal of virus eradication 177 views
19
Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial
Merat, Shahin;SD1000 Research Team;
2020 clinical infectious diseases 194 views
20
predictors of the efficiency of short-term interferon-containing therapy using direct-acting antiviral drugs in patients with chronic hepatitis c virus genotype 1
;K Yu Kokina;A O Bueverov;P O Bogomolov;M V Matsievich
2017 indian journal of chemical technology DOI: 10.17116/terarkh2017... 202 views
22
hyperbilirubinemia without transaminitis during combined therapy with daclatasvir and asunaprevir
;Hayato Baba;Kazuto Tajiri;Kohei Nagata;Kengo Kawai;Masami Minemura;Toshiro Sugiyama
2016 trends in genetics : tig DOI: 10.1159/000447486 191 views

Related Journals

The American journal of Chinese medicine
ISSN: 1793-6853 500 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

hcv amentoflavone orobol resistance-associated variant india hemodialysis daa urology